MA
XBI icon

Montag & Associates’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Montag & Associates’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.72M Buy
68,236
+12,089
+22% +$1.51M 0.4% 60
2025
Q4 		$6.85M Buy
+56,147
New +$6.44M 0.31% 68
2025
Q2 		– Sell
-600
Closed -$48.7K – 1031
2025
Q1 		$48.7K Hold
600
– – ﹤0.01% 624
2024
Q4 		$54K Sell
600
-40,809
-99% -$3.95M ﹤0.01% 596
2024
Q3 		$4.09M Buy
41,409
+3,584
+9% +$352K 0.19% 112
2024
Q2 		$3.51M Buy
37,825
+323
+0.9% +$29K 0.18% 122
2024
Q1 		$3.56M Buy
37,502
+34,652
+1,216% +$3.22M 0.18% 123
2023
Q4 		$254K Hold
2,850
– – 0.01% 374
2023
Q3 		$208K Hold
2,850
– – 0.01% 375
2023
Q2 		$237K Sell
2,850
-835
-23% -$69.8K 0.01% 378
2023
Q1 		$281K Hold
3,685
– – 0.02% 342
2022
Q4 		$306K Sell
3,685
-1,411
-28% -$114K 0.02% 317
2022
Q3 		$404K Buy
5,096
+435
+9% +$36.7K 0.03% 278
2022
Q2 		$346K Hold
4,661
– – 0.02% 306
2022
Q1 		$419K Hold
4,661
– – 0.02% 311
2021
Q4 		$522K Buy
4,661
+406
+10% +$49K 0.03% 293
2021
Q3 		$535K Hold
4,255
– – 0.03% 285
2021
Q2 		$576K Hold
4,255
– – 0.03% 282
2021
Q1 		$577K Buy
4,255
+5
+0.1% +$749 0.03% 280
2020
Q4 		$598K Hold
4,250
– – 0.04% 258
2020
Q3 		$474K Hold
4,250
– – 0.04% 233
2020
Q2 		$476K Hold
4,250
– – 0.04% 223
2020
Q1 		$329K Buy
4,250
+1,250
+42% +$111K 0.03% 240
2019
Q4 		$285K Hold
3,000
– – 0.02% 266
2019
Q3 		$229K Hold
3,000
– – 0.02% 279
2019
Q2 		$263K Hold
3,000
– – 0.02% 274
2019
Q1 		$272K Hold
3,000
– – 0.03% 270
2018
Q4 		$215K Sell
3,000
-2,750
-48% -$222K 0.02% 272
2018
Q3 		$551K Buy
+5,750
New +$557K 0.05% 233

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Montag & Associates's XBI Position: Q1 2026 in Review

Montag & Associates increased its State Street SPDR S&P Biotech ETF (XBI) stake by 22% in Q1 2026, buying an estimated $1.51M and bringing the position to 68,236 shares worth $8.72M. The position accounts for 0.4% of the portfolio, ranked #60.

Montag & Associates first reported a position in XBI in Q3 2018 and has held it in 29 quarters since. 814 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Montag & Associates held 68,236 shares of State Street SPDR S&P Biotech ETF worth $8.72M as of Q1 2026.
  • Montag & Associates bought 12,089 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $1.51M.
  • State Street SPDR S&P Biotech ETF made up 0.4% of Montag & Associates's portfolio in Q1 2026, its #60 holding.
  • Montag & Associates first reported a position in State Street SPDR S&P Biotech ETF in Q3 2018 and has held it in 29 quarters since.
  • 814 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.